Your browser doesn't support javascript.
What gastroenterologists should know during COVID-19 Pandemic!
Kamani, Lubna.
  • Kamani L; Lubna Kamani, MBBS, FCPS, MRCP (UK), FRCP (London), FACG Associate Professor and Director GI Residency Program, Department of Gastroenterology, Liaquat National Hospital, Karachi, Pakistan.
Pak J Med Sci ; 36(COVID19-S4): S124-S125, 2020 May.
Article in English | MEDLINE | ID: covidwho-1726821
ABSTRACT
The WHO has declared a Pandemic due to Novel Corona virus-19 (COVID-19). Patients usually have respiratory symptoms but gastrointestinal and hepatic dysfunction are not uncommon presentations and can lead to a delay in diagnosis and management. Virus shedding can continue even after the nasopharyngeal swab gets negative and could lead to faecal-oral transmission. The effects of COVID-19 on patients with decompensated liver disease is still not clear. Managing immunosuppressive drugs in liver transplant and inflammatory bowel disease is a major challenge without clear guidelines. Only emergency endoscopy is to be done with personal protection equipment. Chloroquine and Hydroxychloroquine has shown some beneficial effects and is being used off-label. Without effective treatment, it is imperative to take precautionary measures.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Pak J Med Sci Year: 2020 Document Type: Article Affiliation country: Pjms.36.COVID19-S4.2651

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Pak J Med Sci Year: 2020 Document Type: Article Affiliation country: Pjms.36.COVID19-S4.2651